相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Functionally Masked Antibody to Uncouple Immune-Related Toxicities in Checkpoint Blockade Cancer Therapy
Seok Ho Song et al.
ACS NANO (2023)
Current Strategies in Photodynamic Therapy (PDT) and Photodynamic Diagnostics (PDD) and the Future Potential of Nanotechnology in Cancer Treatment
Marta Olszowy et al.
PHARMACEUTICS (2023)
Precision-activated T-cell engagers targeting HER2 or EGFR and CD3 mitigate on-target, off-tumor toxicity for immunotherapy in solid tumors
Fiore Cattaruzza et al.
NATURE CANCER (2023)
Incorporation of a repeated polypeptide sequence in therapeutic antibodies as a universal masking procedure: A case study of T cell-engaging bispecific antibodies
Atsushi Maejima et al.
NEW BIOTECHNOLOGY (2023)
Efgartigimod: First Approval
Young-A Heo
DRUGS (2022)
Conjugation of glucosylated polymer chains to checkpoint blockade antibodies augments their efficacy and specificity for glioblastoma
Tao Yang et al.
NATURE BIOMEDICAL ENGINEERING (2021)
The Masking Game: Design of Activatable Antibodies and Mimetics for Selective Therapeutics and Cell Control
Roberta Lucchi et al.
ACS CENTRAL SCIENCE (2021)
Highly accurate protein structure prediction with AlphaFold
John Jumper et al.
NATURE (2021)
Programmable Bivalent Peptide-DNA Locks for pH-Based Control of Antibody Activity
Wouter Engelen et al.
ACS CENTRAL SCIENCE (2020)
Long circulating genetically encoded intrinsically disordered zwitterionic polypeptides for drug delivery
Samagya Banskota et al.
BIOMATERIALS (2019)
Optical Control of Antibody Activity by Using Photocleavable Bivalent Peptide-DNA Locks
Simone F. A. Wouters et al.
CHEMBIOCHEM (2019)
A coiled-coil masking domain for selective activation of therapeutic antibodies
Vivian H. Trang et al.
NATURE BIOTECHNOLOGY (2019)
Next generation antibody drugs: pursuit of the 'high-hanging fruit'
Paul J. Carter et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Rapid and Efficient Generation of Stable Antibody-Drug Conjugates via an Encoded Cyclopropene and an Inverse-Electron-Demand Diels-Alder Reaction
Benjami Oller-Salvia et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
The role of CD133 in cancer: a concise review
Paige M. Glumac et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2018)
Rational Design of Antirheumatic Prodrugs Specific for Sites of Inflammation
Shimobi C. Onuoha et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Expression, production, and renaturation of a functional single-chain variable antibody fragment (scFv) against human ICAM-1
H. Sun et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2014)
Localized In Vivo Activation of a Photoactivatable Doxorubicin Prodrug in Deep Tumor Tissue
Stuart Ibsen et al.
PHOTOCHEMISTRY AND PHOTOBIOLOGY (2013)
Tumor-Specific Activation of an EGFR-Targeting Probody Enhances Therapeutic Index
Luc R. Desnoyers et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Identification and characterization of a novel scFv recognizing human and mouse CD133
Suresh Kumar Swaminathan et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2013)
Matrix metalloproteinase-activated doxorubicin prodrugs inhibit HT1080 xenograft growth doxorubicin with less toxicity
CF Albright et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Novel antitumor prodrugs designed for activation by matrix metalloproteinases-2 and-9
Toni Kline et al.
MOLECULAR PHARMACEUTICS (2004)
Development and in vitro efficacy of novel MMP2 and MMP9 specific doxorubicin albumin conjugates
F Kratz et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)